Physician profile
Duane A Bryan
NPI 1457370728
$17,003.83
in general payments reported to CMS, 2019-2025
49 companies · $2,485 in 2025
The $2,485 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,781 · 2020: $1,497 · 2021: $2,012 · 2022: $3,052 · 2023: $4,239 · 2024: $1,938 · 2025: $2,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,662 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,662.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $3,257.53 | 2019-2025 | |
| Medtronic, INC. | $1,310.46 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Janssen Pharmaceuticals, INC | $1,069.29 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $1,019.59 | 2019-2025 | Farxiga |
| Boston Scientific Corporation | $947.83 | 2019-2025 | General - Therapies, Emblem Mri S-Icd, Resonate El Icd Vr |
| Novartis Pharmaceuticals Corporation | $838.04 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $769.00 | 2020-2025 | Jardiance |
| Abbott Laboratories | $689.11 | 2019-2024 | Jot Dx, Aveir, Mitraclip |
| Biotronik INC. | $599.63 | 2019 | |
| Amgen INC. | $581.79 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $540.30 | 2021-2025 | Verquvo, Capvaxive |
| Edwards Lifesciences Corporation | $539.35 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $487.88 | 2019-2025 | Eliquis, Camzyos |
| Arbor Pharmaceuticals, INC. | $442.89 | 2019-2022 | |
| Novo Nordisk INC | $431.19 | 2020-2025 | Rybelsus, Ozempic |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $344.32 | 2019-2024 | |
| Amarin Pharma, INC. | $281.63 | 2019-2023 | |
| Medtronic Vascular, INC. | $275.25 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $244.40 | 2020-2025 | Onpattro |
| Scpharmaceuticals INC. | $235.16 | 2024-2025 | |
| Lundbeck LLC | $177.40 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $158.06 | 2023-2024 | Inpefa |
| Regeneron Healthcare Solutions, INC. | $157.07 | 2019-2023 | Evkeeza |
| Kowa Pharmaceuticals America, INC. | $156.01 | 2020-2024 | Livalo |
| W. L. Gore & Associates, INC. | $149.86 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $133.04 | 2023-2025 | |
| Medicomp INC | $132.24 | 2022-2024 | Telepatch Cardiac Monitor |
| Azurity Pharmaceuticals, INC. | $114.92 | 2023-2025 | Edarbi, Edarbi |
| Irhythm Technologies, INC. | $110.71 | 2020-2024 | Zio Monitor, Zio Xt Patch |
| Bardy Diagnostics, INC. | $106.58 | 2020-2022 | |
| Baxter Healthcare | $102.63 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Esperion Therapeutics, INC. | $96.52 | 2020-2024 | Nexletol |
| Glaxosmithkline, LLC. | $65.92 | 2025 | Arexvy, Shingrix |
| Bridgebio Pharma, INC. | $56.02 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, LTD. | $54.78 | 2022-2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $43.74 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $34.57 | 2022 | |
| G Medical Diagnostic Services, INC. | $31.91 | 2020-2022 | |
| Heartflow, INC. | $30.22 | 2024 | |
| Genzyme Corporation | $28.27 | 2023 | |
| Amryt Pharma Holdings LTD | $21.28 | 2021 | |
| Portola Pharmaceuticals, LLC | $21.25 | 2019 | |
| Exact Sciences Corporation | $20.15 | 2024 | Cologuard Collection Kit |
| Cvrx, INC. | $19.22 | 2023 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $16.45 | 2024 | Arcalyst |
| Lilly USA, LLC | $15.99 | 2025 | Mounjaro, Zepbound |
| Avanir Pharmaceuticals, INC. | $14.83 | 2019 | |
| Celgene Corporation | $14.82 | 2025 | Camzyos |
| Ge Healthcare | $14.73 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duane Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.